Elyse R Thakur1,2,3, Shubhada Sansgiry1,3,4, Nancy J Petersen1,4, Melinda Stanley1,2,3, Mark E Kunik1,2,3, Aanand D Naik1,4, Jeffrey A Cully5,6,7. 1. Houston VA HSR&D Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC 152), 2002 Holcombe Blvd., Houston, TX, 77030, USA. 2. Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA. 3. VA South Central Mental Illness, Research and Education Clinical Center, Houston, TX, USA. 4. Department of Medicine, Baylor College of Medicine, Houston, TX, USA. 5. Houston VA HSR&D Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC 152), 2002 Holcombe Blvd., Houston, TX, 77030, USA. jcully@bcm.edu. 6. Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA. jcully@bcm.edu. 7. VA South Central Mental Illness, Research and Education Clinical Center, Houston, TX, USA. jcully@bcm.edu.
Abstract
PURPOSE: Guided by the Transactional Model of Stress and Coping, the purpose of this cross-sectional study was to examine clinical factors-demographics, chronic obstructive pulmonary disease (COPD) severity, cognitive/perceptual variables (appraisal and coping)-and their relationship to clinically elevated symptoms of anxiety in a sample of veterans with COPD. METHOD: Participants included a sample of veterans with COPD, with or without comorbid congestive heart failure, and clinically significant symptoms of anxiety (n = 172, mean age = 65.3, SD = 8.1), who previously presented to an outpatient VA setting. Participants completed questionnaires examining COPD severity (respiratory impairment and dyspnea- and fatigue-related quality of life); perceptions of a stressor (COPD illness intrusiveness); perceptions of control (locus of health control, mastery over COPD, self-efficacy); coping strategies (adaptive and maladaptive); and anxiety and depressive symptoms. RESULTS: Multivariable linear regressions revealed that anxiety was positively associated with more maladaptive coping and locus of control (attributed to other people), above and beyond disease severity, demographics, and depressive symptoms. CONCLUSION: These findings suggest that cognitive and perceptual factors are concurrent with anxiety; however, longitudinal investigations are needed to fully understand this relationship. Future research should also focus on identifying optimal assessment and treatment procedures when evaluating and treating patients with COPD and symptoms of anxiety. TRIAL REGISTRATION: NCT01149772.
PURPOSE: Guided by the Transactional Model of Stress and Coping, the purpose of this cross-sectional study was to examine clinical factors-demographics, chronic obstructive pulmonary disease (COPD) severity, cognitive/perceptual variables (appraisal and coping)-and their relationship to clinically elevated symptoms of anxiety in a sample of veterans with COPD. METHOD:Participants included a sample of veterans with COPD, with or without comorbid congestive heart failure, and clinically significant symptoms of anxiety (n = 172, mean age = 65.3, SD = 8.1), who previously presented to an outpatient VA setting. Participants completed questionnaires examining COPD severity (respiratory impairment and dyspnea- and fatigue-related quality of life); perceptions of a stressor (COPD illness intrusiveness); perceptions of control (locus of health control, mastery over COPD, self-efficacy); coping strategies (adaptive and maladaptive); and anxiety and depressive symptoms. RESULTS: Multivariable linear regressions revealed that anxiety was positively associated with more maladaptive coping and locus of control (attributed to other people), above and beyond disease severity, demographics, and depressive symptoms. CONCLUSION: These findings suggest that cognitive and perceptual factors are concurrent with anxiety; however, longitudinal investigations are needed to fully understand this relationship. Future research should also focus on identifying optimal assessment and treatment procedures when evaluating and treating patients with COPD and symptoms of anxiety. TRIAL REGISTRATION: NCT01149772.
Entities:
Keywords:
COPD; Comorbid conditions; Coping; Locus of control; Mental health; Veterans
Authors: Jessica Y Breland; Natalie E Hundt; Terri L Barrera; Joseph Mignogna; Nancy J Petersen; Melinda A Stanley; Jeffery A Cully Journal: Int J Behav Med Date: 2015-10
Authors: Steven De Peuter; Thomas Janssens; Ilse Van Diest; Linda Stans; Thierry Troosters; Marc Decramer; Omer Van den Bergh; Johan W S Vlaeyen Journal: Chron Respir Dis Date: 2010-12-20 Impact factor: 2.444
Authors: Ana Stoilkova; Daisy J A Janssen; Frits M E Franssen; Martijn A Spruit; Emiel F M Wouters Journal: Respir Med Date: 2013-03-29 Impact factor: 3.415
Authors: Natalie E Hundt; Amber B Amspoker; Cynthia Kraus-Schuman; Jeffrey A Cully; Howard Rhoades; Mark E Kunik; Melinda A Stanley Journal: J Anxiety Disord Date: 2014-10-05
Authors: Abdullah M M Alanazi; Mohammed M Alqahtani; Maher M Alquaimi; Tareq F Alotaibi; Saleh S Algarni; Taha T Ismaeil; Ahmad A Alanazi; Moudi M Alasmari; Eyas A Alhuthail; Ali M Alasmari; Linda Gibson-Young; Wasantha P Jayawardene Journal: Int J Environ Res Public Health Date: 2021-12-31 Impact factor: 3.390